Mara Frascaroli
-
- Cancer Treatment and Pharmacology 8
- HER2/EGFR in Cancer Research 6
- Cancer Risks and Factors 2
-
- Breast Cancer Treatment Studies 5
- Cancer Genomics and Diagnostics 3
-
- Advanced Breast Cancer Therapies 5
- Renal cell carcinoma treatment 3
-
- Renal and related cancers 3
- Co-authors
- Guido E. MoroCarlo NapolitanoNicola MonteforteSilvia G. PrioriRaffaella BloiseJannì NastoliAntônio BernardoMaurizia Baldi
- Journals
- Journal of Clinical Oncology (4 papers)SHILAP Revista de lepidopterología (1 paper)Cancer Research (1 paper)
- Partner nations
- ItalyCanadaUnited Kingdom
In The Last Decade
Mara Frascaroli
26 papers receiving 287 citations
Peers
Comparison fields: 5 of 63
- Cardiology and Cardiovascular Medicine 129
- Oncology 88
- Cancer Research 37
- Dermatology 13
- Occupational Therapy 5
Countries citing papers authored by Mara Frascaroli
This map shows the geographic impact of Mara Frascaroli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mara Frascaroli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mara Frascaroli more than expected).
Fields of papers citing papers by Mara Frascaroli
This network shows the impact of papers produced by Mara Frascaroli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mara Frascaroli. The network helps show where Mara Frascaroli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mara Frascaroli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 1 | |
| 3 | 2020 | 27 | |
| 4 | 2019 | 1 | |
| 5 | 2019 | 1 | |
| 6 | 2019 | 1 | |
| 7 | 2018 | 3 | |
| 8 | 2017 | 1 | |
| 9 | 2017 | 7 | |
| 10 | 2016 | 15 | |
| 11 | 2015 | 1 | |
| 12 | 2014 | 1 | |
| 13 | 2013 | 11 | |
| 14 | 2013 | 11 | |
| 15 | 2011 | 11 | |
| 16 | 2009 | 29 | |
| 17 | 2009 | 125 | |
| 18 | 2009 | 6 | |
| 19 | 2008 | 4 | |
| 20 | [Immunotherapy with low-dose subcutaneous interleukin-2 in metastatic renal carcinoma]. | 1993 | 1 |
About Mara Frascaroli
Mara Frascaroli is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 295 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), HER2/EGFR in Cancer Research (6 papers), Advanced Breast Cancer Therapies (5 papers), Breast Cancer Treatment Studies (5 papers), Renal cell carcinoma treatment (3 papers), Renal and related cancers (3 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer Risks and Factors (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (129 citations), Oncology (88 citations) and Cancer Research (37 citations). Mara Frascaroli has collaborated with scholars based in Italy, Canada and United Kingdom. Frequent co-authors include Guido E. Moro, Carlo Napolitano, Nicola Monteforte, Silvia G. Priori, Raffaella Bloise, Jannì Nastoli, Antônio Bernardo, Maurizia Baldi, Paola Baiardi and Oronzo Catalano. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.